|
HRTX Heron Therapeutics Inc de 818033 |
| Balance Sheet |
|
Current Assets
|
195,187,000 |
|
Assets
|
220,777,000 |
|
Current Liabilities
|
85,544,000 |
|
Liabilities
|
260,782,000 |
|
Equity
|
-40,005,000 |
|
Shares Out
|
151,668,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-10,749,000 |
|
Investing Cash Flow
|
7,296,000 |
| Market Analysis |
Market Cap
|
288,927,535 |
|
Price
|
1.63 |
|
BVPS
|
0.70 |
|
PB
|
2.32 |
|
EPS
|
-0.32 |
|
PS
|
2.20 |
|
FCF
|
-3,453,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HRTX documents filed with the SEC.
HRTX Filings
Clear
